Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04083950
EARLY_PHASE1

Induction of Gut Permeability by an Oral Vaccine

Sponsor: USDA, Western Human Nutrition Research Center

View on ClinicalTrials.gov

Summary

This study evaluates the effect of an oral typhoid vaccine on disruption of the intestinal barrier and response of the immune system. Intestinal and whole-body responses will be measured in all participants before and after the vaccine.

Key Details

Gender

FEMALE

Age Range

18 Years - 49 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2019-12-04

Completion Date

2026-09-30

Last Updated

2025-11-24

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Vivotif Typhoid Oral Vaccine

One capsule is swallowed on alternate days, e.g. days 15, 17, 19, and 21, for a total of 4 capsules.

DRUG

Aspirin (Positive Control)

Three tablets (325 mg aspirin in each tablet or 975 mg total) are swallowed on days 2 and 3.

Locations (1)

USDA, ARS, Western Human Nutrition Research Center

Davis, California, United States